−0.0358USD
−8.06 MUSD
39.52 KUSD
158.60 M
About Axim Biotechnologies, Inc.
Sector
CEO
John W. Huemoeller
Headquarters
San Diego
Website
Employees (FY)
7
Founded
2010
ISIN
US05463V1008
FIGI
BBG004F0SHV2
AXIM Biotechnologies, Inc. operates as a biotechnology company, which engages in the development of diagnostic healthcare solutions. Its product categories include Eye Health, SARS-CoV-2, and fentanyl neutralizing antibody test. The company was founded on November 18, 2010 and is headquartered in San Diego, CA.
AXIM Biotechnologies: But opportunity above the 1W MA50.AXIM has turned bullish on the 1W chart (RSI = 64.496, MACD = 0.100, ADX = 26.272) as after the break-out above the 1W MA50 (blue line), it is now on the 3rd straight week of trading above it. This is the first sustainable sequence above the MA50 in years, supported by a strong RSI. That break-out w
Random play on an oversoldI call this my lotto play. Oversold biotech with cannabis roots deep in the business model. With the recent news why not ?
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AXIM is 0.0155 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Axim Biotechnologies, Inc. stocks are traded under the ticker AXIM.
AXIM stock is 24.00% volatile and has beta coefficient of 1.07. Check out the list of the most volatile stocks — is Axim Biotechnologies, Inc. there?
Yes, you can track Axim Biotechnologies, Inc. financials in yearly and quarterly reports right on TradingView.
AXIM stock has risen by 31.91% compared to the previous week, the month change is a 6.90% rise, over the last year Axim Biotechnologies, Inc. has showed a 54.41% decrease.
AXIM net income for the last quarter is −1.90 M USD, while the quarter before that showed 328.47 K USD of net income which accounts for −679.12% change. Track more Axim Biotechnologies, Inc. financial stats to get the full picture.
Today Axim Biotechnologies, Inc. has the market capitalization of 3.68 M, it has increased by 21.36% over the last week.
No, AXIM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AXIM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Axim Biotechnologies, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 7.00 employees. See our rating of the largest employees — is Axim Biotechnologies, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Axim Biotechnologies, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Axim Biotechnologies, Inc. stock shows the sell signal. See more of Axim Biotechnologies, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Axim Biotechnologies, Inc. EBITDA is −2.32 M USD, and current EBITDA margin is −5.88 K%. See more stats in Axim Biotechnologies, Inc. financial statements.